Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Clevenbergh

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Infectious Diseases|August 28, 2002
Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patientP Clevenbergh, M Nkoumou Okome, S Benoit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Brucella melitensis osteitis following craniotomy in a patient with AIDSC Galle, M Struelens, C Liesnard, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 1, 1994
Semi-automatic external defibrillationP Mols, P Clevenbergh, B Henry, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Lancet (London, England)|July 7, 1999
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trialJ Durant, P Clevenbergh, P Halfon, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1996
Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopeniaP Delpire, C M Farber, F Portaels, et al.
HIV Clinical Trials|January 31, 2002
Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patientsP Clevenbergh, E Cua, E Dam, et al.
Infection Prevention in Practice|August 9, 2021
Staggered enforcement of infection control and prevention measures following four consecutive potential laboratory exposures to imported <i>Brucella melitensis</i>V Y Miendje Deyi, M Mori, N Dauby, et al.
HIV Medicine|May 18, 2016
Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patientsP Sellier, A Ostertag, C Collet, et al.
HIV Clinical Trials|December 13, 2006
Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in AfricaP Clevenbergh, S F M Van der Borght, K van Cranenburgh, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Infectious Diseases|August 28, 2002
Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patientP Clevenbergh, M Nkoumou Okome, S Benoit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Brucella melitensis osteitis following craniotomy in a patient with AIDSC Galle, M Struelens, C Liesnard, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 1, 1994
Semi-automatic external defibrillationP Mols, P Clevenbergh, B Henry, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Lancet (London, England)|July 7, 1999
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trialJ Durant, P Clevenbergh, P Halfon, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1996
Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopeniaP Delpire, C M Farber, F Portaels, et al.
HIV Clinical Trials|January 31, 2002
Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patientsP Clevenbergh, E Cua, E Dam, et al.
Infection Prevention in Practice|August 9, 2021
Staggered enforcement of infection control and prevention measures following four consecutive potential laboratory exposures to imported <i>Brucella melitensis</i>V Y Miendje Deyi, M Mori, N Dauby, et al.
HIV Medicine|May 18, 2016
Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patientsP Sellier, A Ostertag, C Collet, et al.
HIV Clinical Trials|December 13, 2006
Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in AfricaP Clevenbergh, S F M Van der Borght, K van Cranenburgh, et al.
Pageof 4